Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Aspect Medical Systems

Today, Aspect is recognized as a pioneer and global market leader in brain monitoring, having led the way to develop proprietary technologies that directly measure these effects and ultimately improve the quality and cost effectiveness of patient care.

Aspect's premier product - Bispectral Index® (BIS®) technology -became the first clinically proven and commercially available direct measure of the effects of anesthetics and sedatives on the brain. At present an estimated 20 million patients undergo surgery with general anesthesia or deep sedation each year in the United States, and an additional 30 million in Europe and Japan. BIS technology allows medical professionals, for the first time, to reliably gauge the precise amount of drug required by each patient, resulting in better overall patient care and fewer undesirable events.


Contact Details:
One Upland Road
Norwood
02062
United States of America
Tel:1-617-559-7000
Fax:1-617-559-7400
Email:bis_info@aspectms.com
WWW:

www.aspectmedical.com/




Recent Publications by Aspect Medical Systems:

Regulatory challenges facing closed-loop anesthetic drug infusion devices.
Closed-loop anesthetic drug infusion devices show great promise for...
8th July, 2008
Aspect Medical Systems, Clin Pharmacol Ther. 2008 Jul;84(1):166-9. Epub 2008 May 7.
DOI Direct Link
A true to life simulation of electrosurgery.
A laboratory simulation has been devised for use in developing and testing...
11th March, 2008
Aspect Medical Systems, Inc., Boston, MA 02464, USA. Conf Proc IEEE Eng Med Biol Soc. 2006;1:5105-8.
DOI Direct Link

Press Releases on Aspect Medical Systems:

BioPortfolio Logo
Reportlinker Adds US Anesthesia and Respiratory Devices Market Analysis & Forecasts to 2015 12th November, 2009 Reportlinker
NEW YORK, Nov. 12 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. US Anesthesia and Respiratory Devices Market Analysis & Forecasts to
Follica Appoints Drug Development and Dermatology Veteran, William D. Ju, as Chief Executive Officer 13th May, 2009 Follica Inc.
BOSTON, May 13 /PRNewswire/ -- Follica Inc., a privately held developer of novel therapies for androgenetic alopecia and other hair follicle and skin disorders, today announced that William D. Ju, M.D
XIFIN Inc. Expands Its Executive Management Team 24th February, 2009 XIFIN, Inc.
SAN DIEGO, Feb. 24 /PRNewswire/ -- XIFIN Inc., the leading provider of revenue cycle management for diagnostic laboratories, announced today that it has added two new members to its Executive
Cosmetic Surgery: PK Anesthesia Safest Achievable 24th February, 2009 Cosmetic Surgery Anesthesia
Like general anesthesia without the risks CORONA DEL MAR, Calif., Feb. 24 /PRNewswire/ -- General anesthesia (GA) remains a popular anesthetic for cosmetic surgery. More enlightened surgeons and
Cosmetic Surgery - No Killer Blood Clots to the Lungs Sans GA, PK Anesthesia Can Save the Day 3rd February, 2009 Cosmetic Surgery Anesthesia
CORONA DEL MAR, Calif., Feb. 3 /PRNewswire/ -- Plastic & Reconstructive Surgery (PRS) Journal, the leading journal in the field, published the remarkable safety record of propofol ketamine (PK)

BioNews Results for Aspect Medical Systems:

FDA Approves New Drug For Pain That Persists After Shingles
MediLexicon:  Nov 19 2009 6:40AM Matching: aspect medical systems
Medical News: FDA Approves New Drug For Pain That Persists After Shingles
BioFind:  Nov 18 2009 10:34PM Matching: aspect medical systems
FDA Approves New Drug For Pain That Persists After Shingles
Medical News Today:  Nov 18 2009 10:46PM Matching: aspect medical systems
BSI Expediting Expansion of In Vitro Diagnostic Scope for Medical Devices
Yahoo! Canada:  Nov 12 2009 11:27PM Matching: aspect medical systems
Covidien Successfully Completes Tender Offer for Shares of Aspect Medical Systems, Inc.
SmartBrief:  Nov 8 2009 11:40AM Matching: aspect medical systems
Promote your company here: BioNewsCast - Press Release Distribution

View more Aspect Medical Systems news.

Aspect Medical Systems Clinical Trials:

EEG Biomarkers for Predicting Response to Antidepressant Therapy

Aspect Medical Systems Patents:

US Patent No.Title
7418290 System and method of assessment of the efficacy of treatment of neurological disorders using the electroencephalogram
6236874 Electrode connector system
6032072 Method for enhancing and separating biopotential signals
6032064 Electrode array system for measuring electrophysiological signals
5813404 Electrode connector system

View more Aspect Medical Systems patents.

Aspect Medical Systems (ASPM) Financial information Links from Barchart

ASPM Quote from from Barchart.com
ASPM Chart from from Barchart.com
ASPM Profile from from Barchart.com
ASPM Opinion from from Barchart.com

View more Aspect Medical Systems finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 321 times since April 2007, the link to the organisation's website has been followed 43 times

Search for more companies in Norwood

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Aspect Medical Systems

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.